Suzhou, China · Founded 2020 · Privately Held (backing)
Developer of biosynthesis designed to provide overall solutions for molecular diagnosis, nucleic acid chemistry, synthetic biology and antibody drug development. Junji Bio is based in Suzhou, China and was founded in 2020. It has raised $14.1 million.
Last price · $/share
—
Implied valuation
—
Total raised
$14.1M
Last round
—
Cap table — not yet on record
Junji Bio's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Junji Bio with a free account
·Watch Junji Bio: the Monday email on marks, rounds and moves
